Global Optical Preclinical Imaging Devices Market
Global Optical Preclinical Imaging Devices Market

Optical Preclinical Imaging Devices Comprehensive Study by Type (Fluorescence/ Bioluminescence Imaging Systems, Standalone Fluorescence Imaging Systems, Optical + X-Ray/Optical + CT), Application (Pharma and Biotech Companies, Research Institutes, Hospital, Others), Reagents Types (Bioluminescent Imaging Reagents, Fluorescent Imaging Reagents), Distribution Channel (Online, Offline) Players and Region - Global Market Outlook to 2025

Optical Preclinical Imaging Devices Market Segmented into XX Submarkets. | Forecast Years: 2020- 2025  

Jun 2020 Edition 211 Pages 213 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Global Optical Preclinical Imaging Devices Market Overview:
Preclinical imaging is the design of live animals for research purposes such as drug development. Imaging techniques were essential for the researchers to observe changes at the organ, tissue, cell, or molecular level in animals that respond to physiological or environmental changes. Imaging modalities that are not aggressive and have become particularly important to examine animal models in the longitudinal direction. These imaging systems can be divided into mainly morphological/anatomical and mainly molecular imaging techniques. Techniques such as high-frequency micro-ultrasound, magnetic resonance imaging (MRI), and computed tomography (CT) are commonly used for anatomical imaging, while optical imaging (fluorescence and bioluminescence), positron emission tomography (PET) and single-photon emission are calculated. Tomography (SPECT) is usually used for molecular visualizations used.

Market Drivers
  • Increasing Geriatric Population across the globe and Growing
  • Highly Demanded Due To Accurate Results
  • Development of Healthcare Infrastructure due to Increasing Healthcare Expenditure

Market Trend
  • Growing Use Of Artificial Intelligence In Medical Imaging
  • Demand In Augmented Reality And Virtual Reality Are New Emerging Applications

Restraints
  • High Risk of Weighing the Radiation

Opportunities
  • Increasing Government and Private Medical Bodies Initiative for Developing Health Care Infrastructure
  • Highly Demanded Due To Different Life-Threatening Disease Requires Quick Diagnostic Results

Challenges
  • Lack of Awareness about Optical Preclinical Imaging Devices among People
  • Lack of Medical Infrastructure in Many Geographical Regions


Competitive Landscape:
The companies are now exploring the market by adopting mergers & acquisitions, expansions, investments, new developments in existing products, and collaborations as their preferred strategies. The players are also exploring new geographies and industries through expansions and acquisitions so as to avail a competitive advantage through combined synergies.
Some of the key players profiled in the report are ThermoFisher Scientific (United States), Bruker Corporation (United States), Perkin Elmer (United States), MR Solutions (United Kingdom), BioTek Instruments (United States), Milabs (Netherlands), FUJIFILM Visualsonics, Inc. (Canada), Magnetic Insight Inc. (United States), MBF Bioscience (United States), Mediso (Budapest), LI-COR Biosciences (United States), Aspect Imaging (Israel), TriFoil Imaging (United States) and Miltenyi Biotech GmbH (Germany). Analyst at AdvanceMarketAnalytics see United States Players to retain maximum share of Global Optical Preclinical Imaging Devices market by 2025. Considering Market by Reagents Types, the sub-segment i.e. Bioluminescent Imaging Reagents will boost the Optical Preclinical Imaging Devices market. Considering Market by Distribution Channel, the sub-segment i.e. Online will boost the Optical Preclinical Imaging Devices market.

Market Highlights:
In December 2019 Fujifilm to Acquire Hitachi’s Diagnostic Imaging-related Business to Accelerate Growth of Its Healthcare Business. FUJIFILM Corporation announced that it has agreed with Hitachi, Ltd. to acquire Hitachi’s Diagnostic Imaging-related Business to further expand its Healthcare business. Fujifilm will acquire all the outstanding shares of the New Company from Hitachi. The completion of this acquisition is subject to customary closing conditions and regulatory approvals.

The Atomic Energy (Radiation Protection) Rules, 2004 [AE(RP)R-2004], promulgated under the Atomic Energy Act, 1962, provides the legal framework for the safe handling of radiation generating equipment. As per Rule 3 of AE(RP)R-2004 it is mandatory for all the manufacturers/Suppliers/Users of x-ray equipment, to obtain requisite ‘Licence’ from AERB for carrying out any kind of activity.

Available Customization:
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be provided prior to purchase

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Optical Preclinical Imaging Devices market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Optical Preclinical Imaging Devices market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Providers of Optical Preclinical Imaging Devices, End-Users, Potential Investors, Market Research Firms, Regulatory Bodies and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.
Report Objectives / Segmentation Covered
By Type
  • Fluorescence/ Bioluminescence Imaging Systems
  • Standalone Fluorescence Imaging Systems
  • Optical + X-Ray/Optical + CT
By Application
  • Pharma and Biotech Companies
  • Research Institutes
  • Hospital
  • Others
By Reagents Types
  • Bioluminescent Imaging Reagents
  • Fluorescent Imaging Reagents

By Distribution Channel
  • Online
  • Offline

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Geriatric Population across the globe and Growing
      • 3.2.2. Highly Demanded Due To Accurate Results
      • 3.2.3. Development of Healthcare Infrastructure due to Increasing Healthcare Expenditure
    • 3.3. Market Challenges
      • 3.3.1. Lack of Awareness about Optical Preclinical Imaging Devices among People
      • 3.3.2. Lack of Medical Infrastructure in Many Geographical Regions
    • 3.4. Market Trends
      • 3.4.1. Growing Use Of Artificial Intelligence In Medical Imaging
      • 3.4.2. Demand In Augmented Reality And Virtual Reality Are New Emerging Applications
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Optical Preclinical Imaging Devices, by Type, Application, Reagents Types, Distribution Channel and Region (value, volume and price ) (2014-2019)
    • 5.1. Introduction
    • 5.2. Global Optical Preclinical Imaging Devices (Value)
      • 5.2.1. Global Optical Preclinical Imaging Devices by: Type (Value)
        • 5.2.1.1. Fluorescence/ Bioluminescence Imaging Systems
        • 5.2.1.2. Standalone Fluorescence Imaging Systems
        • 5.2.1.3. Optical + X-Ray/Optical + CT
      • 5.2.2. Global Optical Preclinical Imaging Devices by: Application (Value)
        • 5.2.2.1. Pharma and Biotech Companies
        • 5.2.2.2. Research Institutes
        • 5.2.2.3. Hospital
        • 5.2.2.4. Others
      • 5.2.3. Global Optical Preclinical Imaging Devices by: Reagents Types (Value)
        • 5.2.3.1. Bioluminescent Imaging Reagents
        • 5.2.3.2. Fluorescent Imaging Reagents
      • 5.2.4. Global Optical Preclinical Imaging Devices by: Distribution Channel (Value)
        • 5.2.4.1. Online
        • 5.2.4.2. Offline
      • 5.2.5. Global Optical Preclinical Imaging Devices Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Optical Preclinical Imaging Devices (Volume)
      • 5.3.1. Global Optical Preclinical Imaging Devices by: Type (Volume)
        • 5.3.1.1. Fluorescence/ Bioluminescence Imaging Systems
        • 5.3.1.2. Standalone Fluorescence Imaging Systems
        • 5.3.1.3. Optical + X-Ray/Optical + CT
      • 5.3.2. Global Optical Preclinical Imaging Devices by: Application (Volume)
        • 5.3.2.1. Pharma and Biotech Companies
        • 5.3.2.2. Research Institutes
        • 5.3.2.3. Hospital
        • 5.3.2.4. Others
      • 5.3.3. Global Optical Preclinical Imaging Devices by: Reagents Types (Volume)
        • 5.3.3.1. Bioluminescent Imaging Reagents
        • 5.3.3.2. Fluorescent Imaging Reagents
      • 5.3.4. Global Optical Preclinical Imaging Devices by: Distribution Channel (Volume)
        • 5.3.4.1. Online
        • 5.3.4.2. Offline
      • 5.3.5. Global Optical Preclinical Imaging Devices Region
        • 5.3.5.1. South America
          • 5.3.5.1.1. Brazil
          • 5.3.5.1.2. Argentina
          • 5.3.5.1.3. Rest of South America
        • 5.3.5.2. Asia Pacific
          • 5.3.5.2.1. China
          • 5.3.5.2.2. Japan
          • 5.3.5.2.3. India
          • 5.3.5.2.4. South Korea
          • 5.3.5.2.5. Taiwan
          • 5.3.5.2.6. Australia
          • 5.3.5.2.7. Rest of Asia-Pacific
        • 5.3.5.3. Europe
          • 5.3.5.3.1. Germany
          • 5.3.5.3.2. France
          • 5.3.5.3.3. Italy
          • 5.3.5.3.4. United Kingdom
          • 5.3.5.3.5. Netherlands
          • 5.3.5.3.6. Rest of Europe
        • 5.3.5.4. MEA
          • 5.3.5.4.1. Middle East
          • 5.3.5.4.2. Africa
        • 5.3.5.5. North America
          • 5.3.5.5.1. United States
          • 5.3.5.5.2. Canada
          • 5.3.5.5.3. Mexico
    • 5.4. Global Optical Preclinical Imaging Devices (Price)
      • 5.4.1. Global Optical Preclinical Imaging Devices by: Type (Price)
  • 6. Optical Preclinical Imaging Devices: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2019)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. ThermoFisher Scientific (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Bruker Corporation (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Perkin Elmer (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. MR Solutions (United Kingdom)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. BioTek Instruments (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Milabs (Netherlands)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. FUJIFILM Visualsonics, Inc. (Canada)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Magnetic Insight Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. MBF Bioscience (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Mediso (Budapest)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. LI-COR Biosciences (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Aspect Imaging (Israel)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
      • 6.4.13. TriFoil Imaging (United States)
        • 6.4.13.1. Business Overview
        • 6.4.13.2. Products/Services Offerings
        • 6.4.13.3. Financial Analysis
        • 6.4.13.4. SWOT Analysis
      • 6.4.14. Miltenyi Biotech GmbH (Germany)
        • 6.4.14.1. Business Overview
        • 6.4.14.2. Products/Services Offerings
        • 6.4.14.3. Financial Analysis
        • 6.4.14.4. SWOT Analysis
  • 7. Global Optical Preclinical Imaging Devices Sale, by Type, Application, Reagents Types, Distribution Channel and Region (value, volume and price ) (2020-2025)
    • 7.1. Introduction
    • 7.2. Global Optical Preclinical Imaging Devices (Value)
      • 7.2.1. Global Optical Preclinical Imaging Devices by: Type (Value)
        • 7.2.1.1. Fluorescence/ Bioluminescence Imaging Systems
        • 7.2.1.2. Standalone Fluorescence Imaging Systems
        • 7.2.1.3. Optical + X-Ray/Optical + CT
      • 7.2.2. Global Optical Preclinical Imaging Devices by: Application (Value)
        • 7.2.2.1. Pharma and Biotech Companies
        • 7.2.2.2. Research Institutes
        • 7.2.2.3. Hospital
        • 7.2.2.4. Others
      • 7.2.3. Global Optical Preclinical Imaging Devices by: Reagents Types (Value)
        • 7.2.3.1. Bioluminescent Imaging Reagents
        • 7.2.3.2. Fluorescent Imaging Reagents
      • 7.2.4. Global Optical Preclinical Imaging Devices by: Distribution Channel (Value)
        • 7.2.4.1. Online
        • 7.2.4.2. Offline
      • 7.2.5. Global Optical Preclinical Imaging Devices Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Optical Preclinical Imaging Devices (Volume)
      • 7.3.1. Global Optical Preclinical Imaging Devices by: Type (Volume)
        • 7.3.1.1. Fluorescence/ Bioluminescence Imaging Systems
        • 7.3.1.2. Standalone Fluorescence Imaging Systems
        • 7.3.1.3. Optical + X-Ray/Optical + CT
      • 7.3.2. Global Optical Preclinical Imaging Devices by: Application (Volume)
        • 7.3.2.1. Pharma and Biotech Companies
        • 7.3.2.2. Research Institutes
        • 7.3.2.3. Hospital
        • 7.3.2.4. Others
      • 7.3.3. Global Optical Preclinical Imaging Devices by: Reagents Types (Volume)
        • 7.3.3.1. Bioluminescent Imaging Reagents
        • 7.3.3.2. Fluorescent Imaging Reagents
      • 7.3.4. Global Optical Preclinical Imaging Devices by: Distribution Channel (Volume)
        • 7.3.4.1. Online
        • 7.3.4.2. Offline
      • 7.3.5. Global Optical Preclinical Imaging Devices Region
        • 7.3.5.1. South America
          • 7.3.5.1.1. Brazil
          • 7.3.5.1.2. Argentina
          • 7.3.5.1.3. Rest of South America
        • 7.3.5.2. Asia Pacific
          • 7.3.5.2.1. China
          • 7.3.5.2.2. Japan
          • 7.3.5.2.3. India
          • 7.3.5.2.4. South Korea
          • 7.3.5.2.5. Taiwan
          • 7.3.5.2.6. Australia
          • 7.3.5.2.7. Rest of Asia-Pacific
        • 7.3.5.3. Europe
          • 7.3.5.3.1. Germany
          • 7.3.5.3.2. France
          • 7.3.5.3.3. Italy
          • 7.3.5.3.4. United Kingdom
          • 7.3.5.3.5. Netherlands
          • 7.3.5.3.6. Rest of Europe
        • 7.3.5.4. MEA
          • 7.3.5.4.1. Middle East
          • 7.3.5.4.2. Africa
        • 7.3.5.5. North America
          • 7.3.5.5.1. United States
          • 7.3.5.5.2. Canada
          • 7.3.5.5.3. Mexico
    • 7.4. Global Optical Preclinical Imaging Devices (Price)
      • 7.4.1. Global Optical Preclinical Imaging Devices by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Optical Preclinical Imaging Devices: by Type(USD Million)
  • Table 2. Optical Preclinical Imaging Devices Fluorescence/ Bioluminescence Imaging Systems , by Region USD Million (2014-2019)
  • Table 3. Optical Preclinical Imaging Devices Standalone Fluorescence Imaging Systems , by Region USD Million (2014-2019)
  • Table 4. Optical Preclinical Imaging Devices Optical + X-Ray/Optical + CT , by Region USD Million (2014-2019)
  • Table 5. Optical Preclinical Imaging Devices: by Application(USD Million)
  • Table 6. Optical Preclinical Imaging Devices Pharma and Biotech Companies , by Region USD Million (2014-2019)
  • Table 7. Optical Preclinical Imaging Devices Research Institutes , by Region USD Million (2014-2019)
  • Table 8. Optical Preclinical Imaging Devices Hospital , by Region USD Million (2014-2019)
  • Table 9. Optical Preclinical Imaging Devices Others , by Region USD Million (2014-2019)
  • Table 10. Optical Preclinical Imaging Devices: by Reagents Types(USD Million)
  • Table 11. Optical Preclinical Imaging Devices Bioluminescent Imaging Reagents , by Region USD Million (2014-2019)
  • Table 12. Optical Preclinical Imaging Devices Fluorescent Imaging Reagents , by Region USD Million (2014-2019)
  • Table 13. Optical Preclinical Imaging Devices: by Distribution Channel(USD Million)
  • Table 14. Optical Preclinical Imaging Devices Online , by Region USD Million (2014-2019)
  • Table 15. Optical Preclinical Imaging Devices Offline , by Region USD Million (2014-2019)
  • Table 16. South America Optical Preclinical Imaging Devices, by Country USD Million (2014-2019)
  • Table 17. South America Optical Preclinical Imaging Devices, by Type USD Million (2014-2019)
  • Table 18. South America Optical Preclinical Imaging Devices, by Application USD Million (2014-2019)
  • Table 19. South America Optical Preclinical Imaging Devices, by Reagents Types USD Million (2014-2019)
  • Table 20. South America Optical Preclinical Imaging Devices, by Distribution Channel USD Million (2014-2019)
  • Table 21. Brazil Optical Preclinical Imaging Devices, by Type USD Million (2014-2019)
  • Table 22. Brazil Optical Preclinical Imaging Devices, by Application USD Million (2014-2019)
  • Table 23. Brazil Optical Preclinical Imaging Devices, by Reagents Types USD Million (2014-2019)
  • Table 24. Brazil Optical Preclinical Imaging Devices, by Distribution Channel USD Million (2014-2019)
  • Table 25. Argentina Optical Preclinical Imaging Devices, by Type USD Million (2014-2019)
  • Table 26. Argentina Optical Preclinical Imaging Devices, by Application USD Million (2014-2019)
  • Table 27. Argentina Optical Preclinical Imaging Devices, by Reagents Types USD Million (2014-2019)
  • Table 28. Argentina Optical Preclinical Imaging Devices, by Distribution Channel USD Million (2014-2019)
  • Table 29. Rest of South America Optical Preclinical Imaging Devices, by Type USD Million (2014-2019)
  • Table 30. Rest of South America Optical Preclinical Imaging Devices, by Application USD Million (2014-2019)
  • Table 31. Rest of South America Optical Preclinical Imaging Devices, by Reagents Types USD Million (2014-2019)
  • Table 32. Rest of South America Optical Preclinical Imaging Devices, by Distribution Channel USD Million (2014-2019)
  • Table 33. Asia Pacific Optical Preclinical Imaging Devices, by Country USD Million (2014-2019)
  • Table 34. Asia Pacific Optical Preclinical Imaging Devices, by Type USD Million (2014-2019)
  • Table 35. Asia Pacific Optical Preclinical Imaging Devices, by Application USD Million (2014-2019)
  • Table 36. Asia Pacific Optical Preclinical Imaging Devices, by Reagents Types USD Million (2014-2019)
  • Table 37. Asia Pacific Optical Preclinical Imaging Devices, by Distribution Channel USD Million (2014-2019)
  • Table 38. China Optical Preclinical Imaging Devices, by Type USD Million (2014-2019)
  • Table 39. China Optical Preclinical Imaging Devices, by Application USD Million (2014-2019)
  • Table 40. China Optical Preclinical Imaging Devices, by Reagents Types USD Million (2014-2019)
  • Table 41. China Optical Preclinical Imaging Devices, by Distribution Channel USD Million (2014-2019)
  • Table 42. Japan Optical Preclinical Imaging Devices, by Type USD Million (2014-2019)
  • Table 43. Japan Optical Preclinical Imaging Devices, by Application USD Million (2014-2019)
  • Table 44. Japan Optical Preclinical Imaging Devices, by Reagents Types USD Million (2014-2019)
  • Table 45. Japan Optical Preclinical Imaging Devices, by Distribution Channel USD Million (2014-2019)
  • Table 46. India Optical Preclinical Imaging Devices, by Type USD Million (2014-2019)
  • Table 47. India Optical Preclinical Imaging Devices, by Application USD Million (2014-2019)
  • Table 48. India Optical Preclinical Imaging Devices, by Reagents Types USD Million (2014-2019)
  • Table 49. India Optical Preclinical Imaging Devices, by Distribution Channel USD Million (2014-2019)
  • Table 50. South Korea Optical Preclinical Imaging Devices, by Type USD Million (2014-2019)
  • Table 51. South Korea Optical Preclinical Imaging Devices, by Application USD Million (2014-2019)
  • Table 52. South Korea Optical Preclinical Imaging Devices, by Reagents Types USD Million (2014-2019)
  • Table 53. South Korea Optical Preclinical Imaging Devices, by Distribution Channel USD Million (2014-2019)
  • Table 54. Taiwan Optical Preclinical Imaging Devices, by Type USD Million (2014-2019)
  • Table 55. Taiwan Optical Preclinical Imaging Devices, by Application USD Million (2014-2019)
  • Table 56. Taiwan Optical Preclinical Imaging Devices, by Reagents Types USD Million (2014-2019)
  • Table 57. Taiwan Optical Preclinical Imaging Devices, by Distribution Channel USD Million (2014-2019)
  • Table 58. Australia Optical Preclinical Imaging Devices, by Type USD Million (2014-2019)
  • Table 59. Australia Optical Preclinical Imaging Devices, by Application USD Million (2014-2019)
  • Table 60. Australia Optical Preclinical Imaging Devices, by Reagents Types USD Million (2014-2019)
  • Table 61. Australia Optical Preclinical Imaging Devices, by Distribution Channel USD Million (2014-2019)
  • Table 62. Rest of Asia-Pacific Optical Preclinical Imaging Devices, by Type USD Million (2014-2019)
  • Table 63. Rest of Asia-Pacific Optical Preclinical Imaging Devices, by Application USD Million (2014-2019)
  • Table 64. Rest of Asia-Pacific Optical Preclinical Imaging Devices, by Reagents Types USD Million (2014-2019)
  • Table 65. Rest of Asia-Pacific Optical Preclinical Imaging Devices, by Distribution Channel USD Million (2014-2019)
  • Table 66. Europe Optical Preclinical Imaging Devices, by Country USD Million (2014-2019)
  • Table 67. Europe Optical Preclinical Imaging Devices, by Type USD Million (2014-2019)
  • Table 68. Europe Optical Preclinical Imaging Devices, by Application USD Million (2014-2019)
  • Table 69. Europe Optical Preclinical Imaging Devices, by Reagents Types USD Million (2014-2019)
  • Table 70. Europe Optical Preclinical Imaging Devices, by Distribution Channel USD Million (2014-2019)
  • Table 71. Germany Optical Preclinical Imaging Devices, by Type USD Million (2014-2019)
  • Table 72. Germany Optical Preclinical Imaging Devices, by Application USD Million (2014-2019)
  • Table 73. Germany Optical Preclinical Imaging Devices, by Reagents Types USD Million (2014-2019)
  • Table 74. Germany Optical Preclinical Imaging Devices, by Distribution Channel USD Million (2014-2019)
  • Table 75. France Optical Preclinical Imaging Devices, by Type USD Million (2014-2019)
  • Table 76. France Optical Preclinical Imaging Devices, by Application USD Million (2014-2019)
  • Table 77. France Optical Preclinical Imaging Devices, by Reagents Types USD Million (2014-2019)
  • Table 78. France Optical Preclinical Imaging Devices, by Distribution Channel USD Million (2014-2019)
  • Table 79. Italy Optical Preclinical Imaging Devices, by Type USD Million (2014-2019)
  • Table 80. Italy Optical Preclinical Imaging Devices, by Application USD Million (2014-2019)
  • Table 81. Italy Optical Preclinical Imaging Devices, by Reagents Types USD Million (2014-2019)
  • Table 82. Italy Optical Preclinical Imaging Devices, by Distribution Channel USD Million (2014-2019)
  • Table 83. United Kingdom Optical Preclinical Imaging Devices, by Type USD Million (2014-2019)
  • Table 84. United Kingdom Optical Preclinical Imaging Devices, by Application USD Million (2014-2019)
  • Table 85. United Kingdom Optical Preclinical Imaging Devices, by Reagents Types USD Million (2014-2019)
  • Table 86. United Kingdom Optical Preclinical Imaging Devices, by Distribution Channel USD Million (2014-2019)
  • Table 87. Netherlands Optical Preclinical Imaging Devices, by Type USD Million (2014-2019)
  • Table 88. Netherlands Optical Preclinical Imaging Devices, by Application USD Million (2014-2019)
  • Table 89. Netherlands Optical Preclinical Imaging Devices, by Reagents Types USD Million (2014-2019)
  • Table 90. Netherlands Optical Preclinical Imaging Devices, by Distribution Channel USD Million (2014-2019)
  • Table 91. Rest of Europe Optical Preclinical Imaging Devices, by Type USD Million (2014-2019)
  • Table 92. Rest of Europe Optical Preclinical Imaging Devices, by Application USD Million (2014-2019)
  • Table 93. Rest of Europe Optical Preclinical Imaging Devices, by Reagents Types USD Million (2014-2019)
  • Table 94. Rest of Europe Optical Preclinical Imaging Devices, by Distribution Channel USD Million (2014-2019)
  • Table 95. MEA Optical Preclinical Imaging Devices, by Country USD Million (2014-2019)
  • Table 96. MEA Optical Preclinical Imaging Devices, by Type USD Million (2014-2019)
  • Table 97. MEA Optical Preclinical Imaging Devices, by Application USD Million (2014-2019)
  • Table 98. MEA Optical Preclinical Imaging Devices, by Reagents Types USD Million (2014-2019)
  • Table 99. MEA Optical Preclinical Imaging Devices, by Distribution Channel USD Million (2014-2019)
  • Table 100. Middle East Optical Preclinical Imaging Devices, by Type USD Million (2014-2019)
  • Table 101. Middle East Optical Preclinical Imaging Devices, by Application USD Million (2014-2019)
  • Table 102. Middle East Optical Preclinical Imaging Devices, by Reagents Types USD Million (2014-2019)
  • Table 103. Middle East Optical Preclinical Imaging Devices, by Distribution Channel USD Million (2014-2019)
  • Table 104. Africa Optical Preclinical Imaging Devices, by Type USD Million (2014-2019)
  • Table 105. Africa Optical Preclinical Imaging Devices, by Application USD Million (2014-2019)
  • Table 106. Africa Optical Preclinical Imaging Devices, by Reagents Types USD Million (2014-2019)
  • Table 107. Africa Optical Preclinical Imaging Devices, by Distribution Channel USD Million (2014-2019)
  • Table 108. North America Optical Preclinical Imaging Devices, by Country USD Million (2014-2019)
  • Table 109. North America Optical Preclinical Imaging Devices, by Type USD Million (2014-2019)
  • Table 110. North America Optical Preclinical Imaging Devices, by Application USD Million (2014-2019)
  • Table 111. North America Optical Preclinical Imaging Devices, by Reagents Types USD Million (2014-2019)
  • Table 112. North America Optical Preclinical Imaging Devices, by Distribution Channel USD Million (2014-2019)
  • Table 113. United States Optical Preclinical Imaging Devices, by Type USD Million (2014-2019)
  • Table 114. United States Optical Preclinical Imaging Devices, by Application USD Million (2014-2019)
  • Table 115. United States Optical Preclinical Imaging Devices, by Reagents Types USD Million (2014-2019)
  • Table 116. United States Optical Preclinical Imaging Devices, by Distribution Channel USD Million (2014-2019)
  • Table 117. Canada Optical Preclinical Imaging Devices, by Type USD Million (2014-2019)
  • Table 118. Canada Optical Preclinical Imaging Devices, by Application USD Million (2014-2019)
  • Table 119. Canada Optical Preclinical Imaging Devices, by Reagents Types USD Million (2014-2019)
  • Table 120. Canada Optical Preclinical Imaging Devices, by Distribution Channel USD Million (2014-2019)
  • Table 121. Mexico Optical Preclinical Imaging Devices, by Type USD Million (2014-2019)
  • Table 122. Mexico Optical Preclinical Imaging Devices, by Application USD Million (2014-2019)
  • Table 123. Mexico Optical Preclinical Imaging Devices, by Reagents Types USD Million (2014-2019)
  • Table 124. Mexico Optical Preclinical Imaging Devices, by Distribution Channel USD Million (2014-2019)
  • Table 125. Optical Preclinical Imaging Devices Sales: by Type(K Units)
  • Table 126. Optical Preclinical Imaging Devices Sales Fluorescence/ Bioluminescence Imaging Systems , by Region K Units (2014-2019)
  • Table 127. Optical Preclinical Imaging Devices Sales Standalone Fluorescence Imaging Systems , by Region K Units (2014-2019)
  • Table 128. Optical Preclinical Imaging Devices Sales Optical + X-Ray/Optical + CT , by Region K Units (2014-2019)
  • Table 129. Optical Preclinical Imaging Devices Sales: by Application(K Units)
  • Table 130. Optical Preclinical Imaging Devices Sales Pharma and Biotech Companies , by Region K Units (2014-2019)
  • Table 131. Optical Preclinical Imaging Devices Sales Research Institutes , by Region K Units (2014-2019)
  • Table 132. Optical Preclinical Imaging Devices Sales Hospital , by Region K Units (2014-2019)
  • Table 133. Optical Preclinical Imaging Devices Sales Others , by Region K Units (2014-2019)
  • Table 134. Optical Preclinical Imaging Devices Sales: by Reagents Types(K Units)
  • Table 135. Optical Preclinical Imaging Devices Sales Bioluminescent Imaging Reagents , by Region K Units (2014-2019)
  • Table 136. Optical Preclinical Imaging Devices Sales Fluorescent Imaging Reagents , by Region K Units (2014-2019)
  • Table 137. Optical Preclinical Imaging Devices Sales: by Distribution Channel(K Units)
  • Table 138. Optical Preclinical Imaging Devices Sales Online , by Region K Units (2014-2019)
  • Table 139. Optical Preclinical Imaging Devices Sales Offline , by Region K Units (2014-2019)
  • Table 140. South America Optical Preclinical Imaging Devices Sales, by Country K Units (2014-2019)
  • Table 141. South America Optical Preclinical Imaging Devices Sales, by Type K Units (2014-2019)
  • Table 142. South America Optical Preclinical Imaging Devices Sales, by Application K Units (2014-2019)
  • Table 143. South America Optical Preclinical Imaging Devices Sales, by Reagents Types K Units (2014-2019)
  • Table 144. South America Optical Preclinical Imaging Devices Sales, by Distribution Channel K Units (2014-2019)
  • Table 145. Brazil Optical Preclinical Imaging Devices Sales, by Type K Units (2014-2019)
  • Table 146. Brazil Optical Preclinical Imaging Devices Sales, by Application K Units (2014-2019)
  • Table 147. Brazil Optical Preclinical Imaging Devices Sales, by Reagents Types K Units (2014-2019)
  • Table 148. Brazil Optical Preclinical Imaging Devices Sales, by Distribution Channel K Units (2014-2019)
  • Table 149. Argentina Optical Preclinical Imaging Devices Sales, by Type K Units (2014-2019)
  • Table 150. Argentina Optical Preclinical Imaging Devices Sales, by Application K Units (2014-2019)
  • Table 151. Argentina Optical Preclinical Imaging Devices Sales, by Reagents Types K Units (2014-2019)
  • Table 152. Argentina Optical Preclinical Imaging Devices Sales, by Distribution Channel K Units (2014-2019)
  • Table 153. Rest of South America Optical Preclinical Imaging Devices Sales, by Type K Units (2014-2019)
  • Table 154. Rest of South America Optical Preclinical Imaging Devices Sales, by Application K Units (2014-2019)
  • Table 155. Rest of South America Optical Preclinical Imaging Devices Sales, by Reagents Types K Units (2014-2019)
  • Table 156. Rest of South America Optical Preclinical Imaging Devices Sales, by Distribution Channel K Units (2014-2019)
  • Table 157. Asia Pacific Optical Preclinical Imaging Devices Sales, by Country K Units (2014-2019)
  • Table 158. Asia Pacific Optical Preclinical Imaging Devices Sales, by Type K Units (2014-2019)
  • Table 159. Asia Pacific Optical Preclinical Imaging Devices Sales, by Application K Units (2014-2019)
  • Table 160. Asia Pacific Optical Preclinical Imaging Devices Sales, by Reagents Types K Units (2014-2019)
  • Table 161. Asia Pacific Optical Preclinical Imaging Devices Sales, by Distribution Channel K Units (2014-2019)
  • Table 162. China Optical Preclinical Imaging Devices Sales, by Type K Units (2014-2019)
  • Table 163. China Optical Preclinical Imaging Devices Sales, by Application K Units (2014-2019)
  • Table 164. China Optical Preclinical Imaging Devices Sales, by Reagents Types K Units (2014-2019)
  • Table 165. China Optical Preclinical Imaging Devices Sales, by Distribution Channel K Units (2014-2019)
  • Table 166. Japan Optical Preclinical Imaging Devices Sales, by Type K Units (2014-2019)
  • Table 167. Japan Optical Preclinical Imaging Devices Sales, by Application K Units (2014-2019)
  • Table 168. Japan Optical Preclinical Imaging Devices Sales, by Reagents Types K Units (2014-2019)
  • Table 169. Japan Optical Preclinical Imaging Devices Sales, by Distribution Channel K Units (2014-2019)
  • Table 170. India Optical Preclinical Imaging Devices Sales, by Type K Units (2014-2019)
  • Table 171. India Optical Preclinical Imaging Devices Sales, by Application K Units (2014-2019)
  • Table 172. India Optical Preclinical Imaging Devices Sales, by Reagents Types K Units (2014-2019)
  • Table 173. India Optical Preclinical Imaging Devices Sales, by Distribution Channel K Units (2014-2019)
  • Table 174. South Korea Optical Preclinical Imaging Devices Sales, by Type K Units (2014-2019)
  • Table 175. South Korea Optical Preclinical Imaging Devices Sales, by Application K Units (2014-2019)
  • Table 176. South Korea Optical Preclinical Imaging Devices Sales, by Reagents Types K Units (2014-2019)
  • Table 177. South Korea Optical Preclinical Imaging Devices Sales, by Distribution Channel K Units (2014-2019)
  • Table 178. Taiwan Optical Preclinical Imaging Devices Sales, by Type K Units (2014-2019)
  • Table 179. Taiwan Optical Preclinical Imaging Devices Sales, by Application K Units (2014-2019)
  • Table 180. Taiwan Optical Preclinical Imaging Devices Sales, by Reagents Types K Units (2014-2019)
  • Table 181. Taiwan Optical Preclinical Imaging Devices Sales, by Distribution Channel K Units (2014-2019)
  • Table 182. Australia Optical Preclinical Imaging Devices Sales, by Type K Units (2014-2019)
  • Table 183. Australia Optical Preclinical Imaging Devices Sales, by Application K Units (2014-2019)
  • Table 184. Australia Optical Preclinical Imaging Devices Sales, by Reagents Types K Units (2014-2019)
  • Table 185. Australia Optical Preclinical Imaging Devices Sales, by Distribution Channel K Units (2014-2019)
  • Table 186. Rest of Asia-Pacific Optical Preclinical Imaging Devices Sales, by Type K Units (2014-2019)
  • Table 187. Rest of Asia-Pacific Optical Preclinical Imaging Devices Sales, by Application K Units (2014-2019)
  • Table 188. Rest of Asia-Pacific Optical Preclinical Imaging Devices Sales, by Reagents Types K Units (2014-2019)
  • Table 189. Rest of Asia-Pacific Optical Preclinical Imaging Devices Sales, by Distribution Channel K Units (2014-2019)
  • Table 190. Europe Optical Preclinical Imaging Devices Sales, by Country K Units (2014-2019)
  • Table 191. Europe Optical Preclinical Imaging Devices Sales, by Type K Units (2014-2019)
  • Table 192. Europe Optical Preclinical Imaging Devices Sales, by Application K Units (2014-2019)
  • Table 193. Europe Optical Preclinical Imaging Devices Sales, by Reagents Types K Units (2014-2019)
  • Table 194. Europe Optical Preclinical Imaging Devices Sales, by Distribution Channel K Units (2014-2019)
  • Table 195. Germany Optical Preclinical Imaging Devices Sales, by Type K Units (2014-2019)
  • Table 196. Germany Optical Preclinical Imaging Devices Sales, by Application K Units (2014-2019)
  • Table 197. Germany Optical Preclinical Imaging Devices Sales, by Reagents Types K Units (2014-2019)
  • Table 198. Germany Optical Preclinical Imaging Devices Sales, by Distribution Channel K Units (2014-2019)
  • Table 199. France Optical Preclinical Imaging Devices Sales, by Type K Units (2014-2019)
  • Table 200. France Optical Preclinical Imaging Devices Sales, by Application K Units (2014-2019)
  • Table 201. France Optical Preclinical Imaging Devices Sales, by Reagents Types K Units (2014-2019)
  • Table 202. France Optical Preclinical Imaging Devices Sales, by Distribution Channel K Units (2014-2019)
  • Table 203. Italy Optical Preclinical Imaging Devices Sales, by Type K Units (2014-2019)
  • Table 204. Italy Optical Preclinical Imaging Devices Sales, by Application K Units (2014-2019)
  • Table 205. Italy Optical Preclinical Imaging Devices Sales, by Reagents Types K Units (2014-2019)
  • Table 206. Italy Optical Preclinical Imaging Devices Sales, by Distribution Channel K Units (2014-2019)
  • Table 207. United Kingdom Optical Preclinical Imaging Devices Sales, by Type K Units (2014-2019)
  • Table 208. United Kingdom Optical Preclinical Imaging Devices Sales, by Application K Units (2014-2019)
  • Table 209. United Kingdom Optical Preclinical Imaging Devices Sales, by Reagents Types K Units (2014-2019)
  • Table 210. United Kingdom Optical Preclinical Imaging Devices Sales, by Distribution Channel K Units (2014-2019)
  • Table 211. Netherlands Optical Preclinical Imaging Devices Sales, by Type K Units (2014-2019)
  • Table 212. Netherlands Optical Preclinical Imaging Devices Sales, by Application K Units (2014-2019)
  • Table 213. Netherlands Optical Preclinical Imaging Devices Sales, by Reagents Types K Units (2014-2019)
  • Table 214. Netherlands Optical Preclinical Imaging Devices Sales, by Distribution Channel K Units (2014-2019)
  • Table 215. Rest of Europe Optical Preclinical Imaging Devices Sales, by Type K Units (2014-2019)
  • Table 216. Rest of Europe Optical Preclinical Imaging Devices Sales, by Application K Units (2014-2019)
  • Table 217. Rest of Europe Optical Preclinical Imaging Devices Sales, by Reagents Types K Units (2014-2019)
  • Table 218. Rest of Europe Optical Preclinical Imaging Devices Sales, by Distribution Channel K Units (2014-2019)
  • Table 219. MEA Optical Preclinical Imaging Devices Sales, by Country K Units (2014-2019)
  • Table 220. MEA Optical Preclinical Imaging Devices Sales, by Type K Units (2014-2019)
  • Table 221. MEA Optical Preclinical Imaging Devices Sales, by Application K Units (2014-2019)
  • Table 222. MEA Optical Preclinical Imaging Devices Sales, by Reagents Types K Units (2014-2019)
  • Table 223. MEA Optical Preclinical Imaging Devices Sales, by Distribution Channel K Units (2014-2019)
  • Table 224. Middle East Optical Preclinical Imaging Devices Sales, by Type K Units (2014-2019)
  • Table 225. Middle East Optical Preclinical Imaging Devices Sales, by Application K Units (2014-2019)
  • Table 226. Middle East Optical Preclinical Imaging Devices Sales, by Reagents Types K Units (2014-2019)
  • Table 227. Middle East Optical Preclinical Imaging Devices Sales, by Distribution Channel K Units (2014-2019)
  • Table 228. Africa Optical Preclinical Imaging Devices Sales, by Type K Units (2014-2019)
  • Table 229. Africa Optical Preclinical Imaging Devices Sales, by Application K Units (2014-2019)
  • Table 230. Africa Optical Preclinical Imaging Devices Sales, by Reagents Types K Units (2014-2019)
  • Table 231. Africa Optical Preclinical Imaging Devices Sales, by Distribution Channel K Units (2014-2019)
  • Table 232. North America Optical Preclinical Imaging Devices Sales, by Country K Units (2014-2019)
  • Table 233. North America Optical Preclinical Imaging Devices Sales, by Type K Units (2014-2019)
  • Table 234. North America Optical Preclinical Imaging Devices Sales, by Application K Units (2014-2019)
  • Table 235. North America Optical Preclinical Imaging Devices Sales, by Reagents Types K Units (2014-2019)
  • Table 236. North America Optical Preclinical Imaging Devices Sales, by Distribution Channel K Units (2014-2019)
  • Table 237. United States Optical Preclinical Imaging Devices Sales, by Type K Units (2014-2019)
  • Table 238. United States Optical Preclinical Imaging Devices Sales, by Application K Units (2014-2019)
  • Table 239. United States Optical Preclinical Imaging Devices Sales, by Reagents Types K Units (2014-2019)
  • Table 240. United States Optical Preclinical Imaging Devices Sales, by Distribution Channel K Units (2014-2019)
  • Table 241. Canada Optical Preclinical Imaging Devices Sales, by Type K Units (2014-2019)
  • Table 242. Canada Optical Preclinical Imaging Devices Sales, by Application K Units (2014-2019)
  • Table 243. Canada Optical Preclinical Imaging Devices Sales, by Reagents Types K Units (2014-2019)
  • Table 244. Canada Optical Preclinical Imaging Devices Sales, by Distribution Channel K Units (2014-2019)
  • Table 245. Mexico Optical Preclinical Imaging Devices Sales, by Type K Units (2014-2019)
  • Table 246. Mexico Optical Preclinical Imaging Devices Sales, by Application K Units (2014-2019)
  • Table 247. Mexico Optical Preclinical Imaging Devices Sales, by Reagents Types K Units (2014-2019)
  • Table 248. Mexico Optical Preclinical Imaging Devices Sales, by Distribution Channel K Units (2014-2019)
  • Table 249. Optical Preclinical Imaging Devices: by Type(USD/Units)
  • Table 250. Company Basic Information, Sales Area and Its Competitors
  • Table 251. Company Basic Information, Sales Area and Its Competitors
  • Table 252. Company Basic Information, Sales Area and Its Competitors
  • Table 253. Company Basic Information, Sales Area and Its Competitors
  • Table 254. Company Basic Information, Sales Area and Its Competitors
  • Table 255. Company Basic Information, Sales Area and Its Competitors
  • Table 256. Company Basic Information, Sales Area and Its Competitors
  • Table 257. Company Basic Information, Sales Area and Its Competitors
  • Table 258. Company Basic Information, Sales Area and Its Competitors
  • Table 259. Company Basic Information, Sales Area and Its Competitors
  • Table 260. Company Basic Information, Sales Area and Its Competitors
  • Table 261. Company Basic Information, Sales Area and Its Competitors
  • Table 262. Company Basic Information, Sales Area and Its Competitors
  • Table 263. Company Basic Information, Sales Area and Its Competitors
  • Table 264. Optical Preclinical Imaging Devices: by Type(USD Million)
  • Table 265. Optical Preclinical Imaging Devices Fluorescence/ Bioluminescence Imaging Systems , by Region USD Million (2020-2025)
  • Table 266. Optical Preclinical Imaging Devices Standalone Fluorescence Imaging Systems , by Region USD Million (2020-2025)
  • Table 267. Optical Preclinical Imaging Devices Optical + X-Ray/Optical + CT , by Region USD Million (2020-2025)
  • Table 268. Optical Preclinical Imaging Devices: by Application(USD Million)
  • Table 269. Optical Preclinical Imaging Devices Pharma and Biotech Companies , by Region USD Million (2020-2025)
  • Table 270. Optical Preclinical Imaging Devices Research Institutes , by Region USD Million (2020-2025)
  • Table 271. Optical Preclinical Imaging Devices Hospital , by Region USD Million (2020-2025)
  • Table 272. Optical Preclinical Imaging Devices Others , by Region USD Million (2020-2025)
  • Table 273. Optical Preclinical Imaging Devices: by Reagents Types(USD Million)
  • Table 274. Optical Preclinical Imaging Devices Bioluminescent Imaging Reagents , by Region USD Million (2020-2025)
  • Table 275. Optical Preclinical Imaging Devices Fluorescent Imaging Reagents , by Region USD Million (2020-2025)
  • Table 276. Optical Preclinical Imaging Devices: by Distribution Channel(USD Million)
  • Table 277. Optical Preclinical Imaging Devices Online , by Region USD Million (2020-2025)
  • Table 278. Optical Preclinical Imaging Devices Offline , by Region USD Million (2020-2025)
  • Table 279. South America Optical Preclinical Imaging Devices, by Country USD Million (2020-2025)
  • Table 280. South America Optical Preclinical Imaging Devices, by Type USD Million (2020-2025)
  • Table 281. South America Optical Preclinical Imaging Devices, by Application USD Million (2020-2025)
  • Table 282. South America Optical Preclinical Imaging Devices, by Reagents Types USD Million (2020-2025)
  • Table 283. South America Optical Preclinical Imaging Devices, by Distribution Channel USD Million (2020-2025)
  • Table 284. Brazil Optical Preclinical Imaging Devices, by Type USD Million (2020-2025)
  • Table 285. Brazil Optical Preclinical Imaging Devices, by Application USD Million (2020-2025)
  • Table 286. Brazil Optical Preclinical Imaging Devices, by Reagents Types USD Million (2020-2025)
  • Table 287. Brazil Optical Preclinical Imaging Devices, by Distribution Channel USD Million (2020-2025)
  • Table 288. Argentina Optical Preclinical Imaging Devices, by Type USD Million (2020-2025)
  • Table 289. Argentina Optical Preclinical Imaging Devices, by Application USD Million (2020-2025)
  • Table 290. Argentina Optical Preclinical Imaging Devices, by Reagents Types USD Million (2020-2025)
  • Table 291. Argentina Optical Preclinical Imaging Devices, by Distribution Channel USD Million (2020-2025)
  • Table 292. Rest of South America Optical Preclinical Imaging Devices, by Type USD Million (2020-2025)
  • Table 293. Rest of South America Optical Preclinical Imaging Devices, by Application USD Million (2020-2025)
  • Table 294. Rest of South America Optical Preclinical Imaging Devices, by Reagents Types USD Million (2020-2025)
  • Table 295. Rest of South America Optical Preclinical Imaging Devices, by Distribution Channel USD Million (2020-2025)
  • Table 296. Asia Pacific Optical Preclinical Imaging Devices, by Country USD Million (2020-2025)
  • Table 297. Asia Pacific Optical Preclinical Imaging Devices, by Type USD Million (2020-2025)
  • Table 298. Asia Pacific Optical Preclinical Imaging Devices, by Application USD Million (2020-2025)
  • Table 299. Asia Pacific Optical Preclinical Imaging Devices, by Reagents Types USD Million (2020-2025)
  • Table 300. Asia Pacific Optical Preclinical Imaging Devices, by Distribution Channel USD Million (2020-2025)
  • Table 301. China Optical Preclinical Imaging Devices, by Type USD Million (2020-2025)
  • Table 302. China Optical Preclinical Imaging Devices, by Application USD Million (2020-2025)
  • Table 303. China Optical Preclinical Imaging Devices, by Reagents Types USD Million (2020-2025)
  • Table 304. China Optical Preclinical Imaging Devices, by Distribution Channel USD Million (2020-2025)
  • Table 305. Japan Optical Preclinical Imaging Devices, by Type USD Million (2020-2025)
  • Table 306. Japan Optical Preclinical Imaging Devices, by Application USD Million (2020-2025)
  • Table 307. Japan Optical Preclinical Imaging Devices, by Reagents Types USD Million (2020-2025)
  • Table 308. Japan Optical Preclinical Imaging Devices, by Distribution Channel USD Million (2020-2025)
  • Table 309. India Optical Preclinical Imaging Devices, by Type USD Million (2020-2025)
  • Table 310. India Optical Preclinical Imaging Devices, by Application USD Million (2020-2025)
  • Table 311. India Optical Preclinical Imaging Devices, by Reagents Types USD Million (2020-2025)
  • Table 312. India Optical Preclinical Imaging Devices, by Distribution Channel USD Million (2020-2025)
  • Table 313. South Korea Optical Preclinical Imaging Devices, by Type USD Million (2020-2025)
  • Table 314. South Korea Optical Preclinical Imaging Devices, by Application USD Million (2020-2025)
  • Table 315. South Korea Optical Preclinical Imaging Devices, by Reagents Types USD Million (2020-2025)
  • Table 316. South Korea Optical Preclinical Imaging Devices, by Distribution Channel USD Million (2020-2025)
  • Table 317. Taiwan Optical Preclinical Imaging Devices, by Type USD Million (2020-2025)
  • Table 318. Taiwan Optical Preclinical Imaging Devices, by Application USD Million (2020-2025)
  • Table 319. Taiwan Optical Preclinical Imaging Devices, by Reagents Types USD Million (2020-2025)
  • Table 320. Taiwan Optical Preclinical Imaging Devices, by Distribution Channel USD Million (2020-2025)
  • Table 321. Australia Optical Preclinical Imaging Devices, by Type USD Million (2020-2025)
  • Table 322. Australia Optical Preclinical Imaging Devices, by Application USD Million (2020-2025)
  • Table 323. Australia Optical Preclinical Imaging Devices, by Reagents Types USD Million (2020-2025)
  • Table 324. Australia Optical Preclinical Imaging Devices, by Distribution Channel USD Million (2020-2025)
  • Table 325. Rest of Asia-Pacific Optical Preclinical Imaging Devices, by Type USD Million (2020-2025)
  • Table 326. Rest of Asia-Pacific Optical Preclinical Imaging Devices, by Application USD Million (2020-2025)
  • Table 327. Rest of Asia-Pacific Optical Preclinical Imaging Devices, by Reagents Types USD Million (2020-2025)
  • Table 328. Rest of Asia-Pacific Optical Preclinical Imaging Devices, by Distribution Channel USD Million (2020-2025)
  • Table 329. Europe Optical Preclinical Imaging Devices, by Country USD Million (2020-2025)
  • Table 330. Europe Optical Preclinical Imaging Devices, by Type USD Million (2020-2025)
  • Table 331. Europe Optical Preclinical Imaging Devices, by Application USD Million (2020-2025)
  • Table 332. Europe Optical Preclinical Imaging Devices, by Reagents Types USD Million (2020-2025)
  • Table 333. Europe Optical Preclinical Imaging Devices, by Distribution Channel USD Million (2020-2025)
  • Table 334. Germany Optical Preclinical Imaging Devices, by Type USD Million (2020-2025)
  • Table 335. Germany Optical Preclinical Imaging Devices, by Application USD Million (2020-2025)
  • Table 336. Germany Optical Preclinical Imaging Devices, by Reagents Types USD Million (2020-2025)
  • Table 337. Germany Optical Preclinical Imaging Devices, by Distribution Channel USD Million (2020-2025)
  • Table 338. France Optical Preclinical Imaging Devices, by Type USD Million (2020-2025)
  • Table 339. France Optical Preclinical Imaging Devices, by Application USD Million (2020-2025)
  • Table 340. France Optical Preclinical Imaging Devices, by Reagents Types USD Million (2020-2025)
  • Table 341. France Optical Preclinical Imaging Devices, by Distribution Channel USD Million (2020-2025)
  • Table 342. Italy Optical Preclinical Imaging Devices, by Type USD Million (2020-2025)
  • Table 343. Italy Optical Preclinical Imaging Devices, by Application USD Million (2020-2025)
  • Table 344. Italy Optical Preclinical Imaging Devices, by Reagents Types USD Million (2020-2025)
  • Table 345. Italy Optical Preclinical Imaging Devices, by Distribution Channel USD Million (2020-2025)
  • Table 346. United Kingdom Optical Preclinical Imaging Devices, by Type USD Million (2020-2025)
  • Table 347. United Kingdom Optical Preclinical Imaging Devices, by Application USD Million (2020-2025)
  • Table 348. United Kingdom Optical Preclinical Imaging Devices, by Reagents Types USD Million (2020-2025)
  • Table 349. United Kingdom Optical Preclinical Imaging Devices, by Distribution Channel USD Million (2020-2025)
  • Table 350. Netherlands Optical Preclinical Imaging Devices, by Type USD Million (2020-2025)
  • Table 351. Netherlands Optical Preclinical Imaging Devices, by Application USD Million (2020-2025)
  • Table 352. Netherlands Optical Preclinical Imaging Devices, by Reagents Types USD Million (2020-2025)
  • Table 353. Netherlands Optical Preclinical Imaging Devices, by Distribution Channel USD Million (2020-2025)
  • Table 354. Rest of Europe Optical Preclinical Imaging Devices, by Type USD Million (2020-2025)
  • Table 355. Rest of Europe Optical Preclinical Imaging Devices, by Application USD Million (2020-2025)
  • Table 356. Rest of Europe Optical Preclinical Imaging Devices, by Reagents Types USD Million (2020-2025)
  • Table 357. Rest of Europe Optical Preclinical Imaging Devices, by Distribution Channel USD Million (2020-2025)
  • Table 358. MEA Optical Preclinical Imaging Devices, by Country USD Million (2020-2025)
  • Table 359. MEA Optical Preclinical Imaging Devices, by Type USD Million (2020-2025)
  • Table 360. MEA Optical Preclinical Imaging Devices, by Application USD Million (2020-2025)
  • Table 361. MEA Optical Preclinical Imaging Devices, by Reagents Types USD Million (2020-2025)
  • Table 362. MEA Optical Preclinical Imaging Devices, by Distribution Channel USD Million (2020-2025)
  • Table 363. Middle East Optical Preclinical Imaging Devices, by Type USD Million (2020-2025)
  • Table 364. Middle East Optical Preclinical Imaging Devices, by Application USD Million (2020-2025)
  • Table 365. Middle East Optical Preclinical Imaging Devices, by Reagents Types USD Million (2020-2025)
  • Table 366. Middle East Optical Preclinical Imaging Devices, by Distribution Channel USD Million (2020-2025)
  • Table 367. Africa Optical Preclinical Imaging Devices, by Type USD Million (2020-2025)
  • Table 368. Africa Optical Preclinical Imaging Devices, by Application USD Million (2020-2025)
  • Table 369. Africa Optical Preclinical Imaging Devices, by Reagents Types USD Million (2020-2025)
  • Table 370. Africa Optical Preclinical Imaging Devices, by Distribution Channel USD Million (2020-2025)
  • Table 371. North America Optical Preclinical Imaging Devices, by Country USD Million (2020-2025)
  • Table 372. North America Optical Preclinical Imaging Devices, by Type USD Million (2020-2025)
  • Table 373. North America Optical Preclinical Imaging Devices, by Application USD Million (2020-2025)
  • Table 374. North America Optical Preclinical Imaging Devices, by Reagents Types USD Million (2020-2025)
  • Table 375. North America Optical Preclinical Imaging Devices, by Distribution Channel USD Million (2020-2025)
  • Table 376. United States Optical Preclinical Imaging Devices, by Type USD Million (2020-2025)
  • Table 377. United States Optical Preclinical Imaging Devices, by Application USD Million (2020-2025)
  • Table 378. United States Optical Preclinical Imaging Devices, by Reagents Types USD Million (2020-2025)
  • Table 379. United States Optical Preclinical Imaging Devices, by Distribution Channel USD Million (2020-2025)
  • Table 380. Canada Optical Preclinical Imaging Devices, by Type USD Million (2020-2025)
  • Table 381. Canada Optical Preclinical Imaging Devices, by Application USD Million (2020-2025)
  • Table 382. Canada Optical Preclinical Imaging Devices, by Reagents Types USD Million (2020-2025)
  • Table 383. Canada Optical Preclinical Imaging Devices, by Distribution Channel USD Million (2020-2025)
  • Table 384. Mexico Optical Preclinical Imaging Devices, by Type USD Million (2020-2025)
  • Table 385. Mexico Optical Preclinical Imaging Devices, by Application USD Million (2020-2025)
  • Table 386. Mexico Optical Preclinical Imaging Devices, by Reagents Types USD Million (2020-2025)
  • Table 387. Mexico Optical Preclinical Imaging Devices, by Distribution Channel USD Million (2020-2025)
  • Table 388. Optical Preclinical Imaging Devices Sales: by Type(K Units)
  • Table 389. Optical Preclinical Imaging Devices Sales Fluorescence/ Bioluminescence Imaging Systems , by Region K Units (2020-2025)
  • Table 390. Optical Preclinical Imaging Devices Sales Standalone Fluorescence Imaging Systems , by Region K Units (2020-2025)
  • Table 391. Optical Preclinical Imaging Devices Sales Optical + X-Ray/Optical + CT , by Region K Units (2020-2025)
  • Table 392. Optical Preclinical Imaging Devices Sales: by Application(K Units)
  • Table 393. Optical Preclinical Imaging Devices Sales Pharma and Biotech Companies , by Region K Units (2020-2025)
  • Table 394. Optical Preclinical Imaging Devices Sales Research Institutes , by Region K Units (2020-2025)
  • Table 395. Optical Preclinical Imaging Devices Sales Hospital , by Region K Units (2020-2025)
  • Table 396. Optical Preclinical Imaging Devices Sales Others , by Region K Units (2020-2025)
  • Table 397. Optical Preclinical Imaging Devices Sales: by Reagents Types(K Units)
  • Table 398. Optical Preclinical Imaging Devices Sales Bioluminescent Imaging Reagents , by Region K Units (2020-2025)
  • Table 399. Optical Preclinical Imaging Devices Sales Fluorescent Imaging Reagents , by Region K Units (2020-2025)
  • Table 400. Optical Preclinical Imaging Devices Sales: by Distribution Channel(K Units)
  • Table 401. Optical Preclinical Imaging Devices Sales Online , by Region K Units (2020-2025)
  • Table 402. Optical Preclinical Imaging Devices Sales Offline , by Region K Units (2020-2025)
  • Table 403. South America Optical Preclinical Imaging Devices Sales, by Country K Units (2020-2025)
  • Table 404. South America Optical Preclinical Imaging Devices Sales, by Type K Units (2020-2025)
  • Table 405. South America Optical Preclinical Imaging Devices Sales, by Application K Units (2020-2025)
  • Table 406. South America Optical Preclinical Imaging Devices Sales, by Reagents Types K Units (2020-2025)
  • Table 407. South America Optical Preclinical Imaging Devices Sales, by Distribution Channel K Units (2020-2025)
  • Table 408. Brazil Optical Preclinical Imaging Devices Sales, by Type K Units (2020-2025)
  • Table 409. Brazil Optical Preclinical Imaging Devices Sales, by Application K Units (2020-2025)
  • Table 410. Brazil Optical Preclinical Imaging Devices Sales, by Reagents Types K Units (2020-2025)
  • Table 411. Brazil Optical Preclinical Imaging Devices Sales, by Distribution Channel K Units (2020-2025)
  • Table 412. Argentina Optical Preclinical Imaging Devices Sales, by Type K Units (2020-2025)
  • Table 413. Argentina Optical Preclinical Imaging Devices Sales, by Application K Units (2020-2025)
  • Table 414. Argentina Optical Preclinical Imaging Devices Sales, by Reagents Types K Units (2020-2025)
  • Table 415. Argentina Optical Preclinical Imaging Devices Sales, by Distribution Channel K Units (2020-2025)
  • Table 416. Rest of South America Optical Preclinical Imaging Devices Sales, by Type K Units (2020-2025)
  • Table 417. Rest of South America Optical Preclinical Imaging Devices Sales, by Application K Units (2020-2025)
  • Table 418. Rest of South America Optical Preclinical Imaging Devices Sales, by Reagents Types K Units (2020-2025)
  • Table 419. Rest of South America Optical Preclinical Imaging Devices Sales, by Distribution Channel K Units (2020-2025)
  • Table 420. Asia Pacific Optical Preclinical Imaging Devices Sales, by Country K Units (2020-2025)
  • Table 421. Asia Pacific Optical Preclinical Imaging Devices Sales, by Type K Units (2020-2025)
  • Table 422. Asia Pacific Optical Preclinical Imaging Devices Sales, by Application K Units (2020-2025)
  • Table 423. Asia Pacific Optical Preclinical Imaging Devices Sales, by Reagents Types K Units (2020-2025)
  • Table 424. Asia Pacific Optical Preclinical Imaging Devices Sales, by Distribution Channel K Units (2020-2025)
  • Table 425. China Optical Preclinical Imaging Devices Sales, by Type K Units (2020-2025)
  • Table 426. China Optical Preclinical Imaging Devices Sales, by Application K Units (2020-2025)
  • Table 427. China Optical Preclinical Imaging Devices Sales, by Reagents Types K Units (2020-2025)
  • Table 428. China Optical Preclinical Imaging Devices Sales, by Distribution Channel K Units (2020-2025)
  • Table 429. Japan Optical Preclinical Imaging Devices Sales, by Type K Units (2020-2025)
  • Table 430. Japan Optical Preclinical Imaging Devices Sales, by Application K Units (2020-2025)
  • Table 431. Japan Optical Preclinical Imaging Devices Sales, by Reagents Types K Units (2020-2025)
  • Table 432. Japan Optical Preclinical Imaging Devices Sales, by Distribution Channel K Units (2020-2025)
  • Table 433. India Optical Preclinical Imaging Devices Sales, by Type K Units (2020-2025)
  • Table 434. India Optical Preclinical Imaging Devices Sales, by Application K Units (2020-2025)
  • Table 435. India Optical Preclinical Imaging Devices Sales, by Reagents Types K Units (2020-2025)
  • Table 436. India Optical Preclinical Imaging Devices Sales, by Distribution Channel K Units (2020-2025)
  • Table 437. South Korea Optical Preclinical Imaging Devices Sales, by Type K Units (2020-2025)
  • Table 438. South Korea Optical Preclinical Imaging Devices Sales, by Application K Units (2020-2025)
  • Table 439. South Korea Optical Preclinical Imaging Devices Sales, by Reagents Types K Units (2020-2025)
  • Table 440. South Korea Optical Preclinical Imaging Devices Sales, by Distribution Channel K Units (2020-2025)
  • Table 441. Taiwan Optical Preclinical Imaging Devices Sales, by Type K Units (2020-2025)
  • Table 442. Taiwan Optical Preclinical Imaging Devices Sales, by Application K Units (2020-2025)
  • Table 443. Taiwan Optical Preclinical Imaging Devices Sales, by Reagents Types K Units (2020-2025)
  • Table 444. Taiwan Optical Preclinical Imaging Devices Sales, by Distribution Channel K Units (2020-2025)
  • Table 445. Australia Optical Preclinical Imaging Devices Sales, by Type K Units (2020-2025)
  • Table 446. Australia Optical Preclinical Imaging Devices Sales, by Application K Units (2020-2025)
  • Table 447. Australia Optical Preclinical Imaging Devices Sales, by Reagents Types K Units (2020-2025)
  • Table 448. Australia Optical Preclinical Imaging Devices Sales, by Distribution Channel K Units (2020-2025)
  • Table 449. Rest of Asia-Pacific Optical Preclinical Imaging Devices Sales, by Type K Units (2020-2025)
  • Table 450. Rest of Asia-Pacific Optical Preclinical Imaging Devices Sales, by Application K Units (2020-2025)
  • Table 451. Rest of Asia-Pacific Optical Preclinical Imaging Devices Sales, by Reagents Types K Units (2020-2025)
  • Table 452. Rest of Asia-Pacific Optical Preclinical Imaging Devices Sales, by Distribution Channel K Units (2020-2025)
  • Table 453. Europe Optical Preclinical Imaging Devices Sales, by Country K Units (2020-2025)
  • Table 454. Europe Optical Preclinical Imaging Devices Sales, by Type K Units (2020-2025)
  • Table 455. Europe Optical Preclinical Imaging Devices Sales, by Application K Units (2020-2025)
  • Table 456. Europe Optical Preclinical Imaging Devices Sales, by Reagents Types K Units (2020-2025)
  • Table 457. Europe Optical Preclinical Imaging Devices Sales, by Distribution Channel K Units (2020-2025)
  • Table 458. Germany Optical Preclinical Imaging Devices Sales, by Type K Units (2020-2025)
  • Table 459. Germany Optical Preclinical Imaging Devices Sales, by Application K Units (2020-2025)
  • Table 460. Germany Optical Preclinical Imaging Devices Sales, by Reagents Types K Units (2020-2025)
  • Table 461. Germany Optical Preclinical Imaging Devices Sales, by Distribution Channel K Units (2020-2025)
  • Table 462. France Optical Preclinical Imaging Devices Sales, by Type K Units (2020-2025)
  • Table 463. France Optical Preclinical Imaging Devices Sales, by Application K Units (2020-2025)
  • Table 464. France Optical Preclinical Imaging Devices Sales, by Reagents Types K Units (2020-2025)
  • Table 465. France Optical Preclinical Imaging Devices Sales, by Distribution Channel K Units (2020-2025)
  • Table 466. Italy Optical Preclinical Imaging Devices Sales, by Type K Units (2020-2025)
  • Table 467. Italy Optical Preclinical Imaging Devices Sales, by Application K Units (2020-2025)
  • Table 468. Italy Optical Preclinical Imaging Devices Sales, by Reagents Types K Units (2020-2025)
  • Table 469. Italy Optical Preclinical Imaging Devices Sales, by Distribution Channel K Units (2020-2025)
  • Table 470. United Kingdom Optical Preclinical Imaging Devices Sales, by Type K Units (2020-2025)
  • Table 471. United Kingdom Optical Preclinical Imaging Devices Sales, by Application K Units (2020-2025)
  • Table 472. United Kingdom Optical Preclinical Imaging Devices Sales, by Reagents Types K Units (2020-2025)
  • Table 473. United Kingdom Optical Preclinical Imaging Devices Sales, by Distribution Channel K Units (2020-2025)
  • Table 474. Netherlands Optical Preclinical Imaging Devices Sales, by Type K Units (2020-2025)
  • Table 475. Netherlands Optical Preclinical Imaging Devices Sales, by Application K Units (2020-2025)
  • Table 476. Netherlands Optical Preclinical Imaging Devices Sales, by Reagents Types K Units (2020-2025)
  • Table 477. Netherlands Optical Preclinical Imaging Devices Sales, by Distribution Channel K Units (2020-2025)
  • Table 478. Rest of Europe Optical Preclinical Imaging Devices Sales, by Type K Units (2020-2025)
  • Table 479. Rest of Europe Optical Preclinical Imaging Devices Sales, by Application K Units (2020-2025)
  • Table 480. Rest of Europe Optical Preclinical Imaging Devices Sales, by Reagents Types K Units (2020-2025)
  • Table 481. Rest of Europe Optical Preclinical Imaging Devices Sales, by Distribution Channel K Units (2020-2025)
  • Table 482. MEA Optical Preclinical Imaging Devices Sales, by Country K Units (2020-2025)
  • Table 483. MEA Optical Preclinical Imaging Devices Sales, by Type K Units (2020-2025)
  • Table 484. MEA Optical Preclinical Imaging Devices Sales, by Application K Units (2020-2025)
  • Table 485. MEA Optical Preclinical Imaging Devices Sales, by Reagents Types K Units (2020-2025)
  • Table 486. MEA Optical Preclinical Imaging Devices Sales, by Distribution Channel K Units (2020-2025)
  • Table 487. Middle East Optical Preclinical Imaging Devices Sales, by Type K Units (2020-2025)
  • Table 488. Middle East Optical Preclinical Imaging Devices Sales, by Application K Units (2020-2025)
  • Table 489. Middle East Optical Preclinical Imaging Devices Sales, by Reagents Types K Units (2020-2025)
  • Table 490. Middle East Optical Preclinical Imaging Devices Sales, by Distribution Channel K Units (2020-2025)
  • Table 491. Africa Optical Preclinical Imaging Devices Sales, by Type K Units (2020-2025)
  • Table 492. Africa Optical Preclinical Imaging Devices Sales, by Application K Units (2020-2025)
  • Table 493. Africa Optical Preclinical Imaging Devices Sales, by Reagents Types K Units (2020-2025)
  • Table 494. Africa Optical Preclinical Imaging Devices Sales, by Distribution Channel K Units (2020-2025)
  • Table 495. North America Optical Preclinical Imaging Devices Sales, by Country K Units (2020-2025)
  • Table 496. North America Optical Preclinical Imaging Devices Sales, by Type K Units (2020-2025)
  • Table 497. North America Optical Preclinical Imaging Devices Sales, by Application K Units (2020-2025)
  • Table 498. North America Optical Preclinical Imaging Devices Sales, by Reagents Types K Units (2020-2025)
  • Table 499. North America Optical Preclinical Imaging Devices Sales, by Distribution Channel K Units (2020-2025)
  • Table 500. United States Optical Preclinical Imaging Devices Sales, by Type K Units (2020-2025)
  • Table 501. United States Optical Preclinical Imaging Devices Sales, by Application K Units (2020-2025)
  • Table 502. United States Optical Preclinical Imaging Devices Sales, by Reagents Types K Units (2020-2025)
  • Table 503. United States Optical Preclinical Imaging Devices Sales, by Distribution Channel K Units (2020-2025)
  • Table 504. Canada Optical Preclinical Imaging Devices Sales, by Type K Units (2020-2025)
  • Table 505. Canada Optical Preclinical Imaging Devices Sales, by Application K Units (2020-2025)
  • Table 506. Canada Optical Preclinical Imaging Devices Sales, by Reagents Types K Units (2020-2025)
  • Table 507. Canada Optical Preclinical Imaging Devices Sales, by Distribution Channel K Units (2020-2025)
  • Table 508. Mexico Optical Preclinical Imaging Devices Sales, by Type K Units (2020-2025)
  • Table 509. Mexico Optical Preclinical Imaging Devices Sales, by Application K Units (2020-2025)
  • Table 510. Mexico Optical Preclinical Imaging Devices Sales, by Reagents Types K Units (2020-2025)
  • Table 511. Mexico Optical Preclinical Imaging Devices Sales, by Distribution Channel K Units (2020-2025)
  • Table 512. Optical Preclinical Imaging Devices: by Type(USD/Units)
  • Table 513. Research Programs/Design for This Report
  • Table 514. Key Data Information from Secondary Sources
  • Table 515. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Optical Preclinical Imaging Devices: by Type USD Million (2014-2019)
  • Figure 5. Global Optical Preclinical Imaging Devices: by Application USD Million (2014-2019)
  • Figure 6. Global Optical Preclinical Imaging Devices: by Reagents Types USD Million (2014-2019)
  • Figure 7. Global Optical Preclinical Imaging Devices: by Distribution Channel USD Million (2014-2019)
  • Figure 8. South America Optical Preclinical Imaging Devices Share (%), by Country
  • Figure 9. Asia Pacific Optical Preclinical Imaging Devices Share (%), by Country
  • Figure 10. Europe Optical Preclinical Imaging Devices Share (%), by Country
  • Figure 11. MEA Optical Preclinical Imaging Devices Share (%), by Country
  • Figure 12. North America Optical Preclinical Imaging Devices Share (%), by Country
  • Figure 13. Global Optical Preclinical Imaging Devices: by Type K Units (2014-2019)
  • Figure 14. Global Optical Preclinical Imaging Devices: by Application K Units (2014-2019)
  • Figure 15. Global Optical Preclinical Imaging Devices: by Reagents Types K Units (2014-2019)
  • Figure 16. Global Optical Preclinical Imaging Devices: by Distribution Channel K Units (2014-2019)
  • Figure 17. South America Optical Preclinical Imaging Devices Share (%), by Country
  • Figure 18. Asia Pacific Optical Preclinical Imaging Devices Share (%), by Country
  • Figure 19. Europe Optical Preclinical Imaging Devices Share (%), by Country
  • Figure 20. MEA Optical Preclinical Imaging Devices Share (%), by Country
  • Figure 21. North America Optical Preclinical Imaging Devices Share (%), by Country
  • Figure 22. Global Optical Preclinical Imaging Devices: by Type USD/Units (2014-2019)
  • Figure 23. Global Optical Preclinical Imaging Devices share by Players 2019 (%)
  • Figure 24. Global Optical Preclinical Imaging Devices share by Players (Top 3) 2019(%)
  • Figure 25. Global Optical Preclinical Imaging Devices share by Players (Top 5) 2019(%)
  • Figure 26. BCG Matrix for key Companies
  • Figure 27. ThermoFisher Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 28. ThermoFisher Scientific (United States) Revenue: by Geography 2019
  • Figure 29. Bruker Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 30. Bruker Corporation (United States) Revenue: by Geography 2019
  • Figure 31. Perkin Elmer (United States) Revenue, Net Income and Gross profit
  • Figure 32. Perkin Elmer (United States) Revenue: by Geography 2019
  • Figure 33. MR Solutions (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 34. MR Solutions (United Kingdom) Revenue: by Geography 2019
  • Figure 35. BioTek Instruments (United States) Revenue, Net Income and Gross profit
  • Figure 36. BioTek Instruments (United States) Revenue: by Geography 2019
  • Figure 37. Milabs (Netherlands) Revenue, Net Income and Gross profit
  • Figure 38. Milabs (Netherlands) Revenue: by Geography 2019
  • Figure 39. FUJIFILM Visualsonics, Inc. (Canada) Revenue, Net Income and Gross profit
  • Figure 40. FUJIFILM Visualsonics, Inc. (Canada) Revenue: by Geography 2019
  • Figure 41. Magnetic Insight Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 42. Magnetic Insight Inc. (United States) Revenue: by Geography 2019
  • Figure 43. MBF Bioscience (United States) Revenue, Net Income and Gross profit
  • Figure 44. MBF Bioscience (United States) Revenue: by Geography 2019
  • Figure 45. Mediso (Budapest) Revenue, Net Income and Gross profit
  • Figure 46. Mediso (Budapest) Revenue: by Geography 2019
  • Figure 47. LI-COR Biosciences (United States) Revenue, Net Income and Gross profit
  • Figure 48. LI-COR Biosciences (United States) Revenue: by Geography 2019
  • Figure 49. Aspect Imaging (Israel) Revenue, Net Income and Gross profit
  • Figure 50. Aspect Imaging (Israel) Revenue: by Geography 2019
  • Figure 51. TriFoil Imaging (United States) Revenue, Net Income and Gross profit
  • Figure 52. TriFoil Imaging (United States) Revenue: by Geography 2019
  • Figure 53. Miltenyi Biotech GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 54. Miltenyi Biotech GmbH (Germany) Revenue: by Geography 2019
  • Figure 55. Global Optical Preclinical Imaging Devices: by Type USD Million (2020-2025)
  • Figure 56. Global Optical Preclinical Imaging Devices: by Application USD Million (2020-2025)
  • Figure 57. Global Optical Preclinical Imaging Devices: by Reagents Types USD Million (2020-2025)
  • Figure 58. Global Optical Preclinical Imaging Devices: by Distribution Channel USD Million (2020-2025)
  • Figure 59. South America Optical Preclinical Imaging Devices Share (%), by Country
  • Figure 60. Asia Pacific Optical Preclinical Imaging Devices Share (%), by Country
  • Figure 61. Europe Optical Preclinical Imaging Devices Share (%), by Country
  • Figure 62. MEA Optical Preclinical Imaging Devices Share (%), by Country
  • Figure 63. North America Optical Preclinical Imaging Devices Share (%), by Country
  • Figure 64. Global Optical Preclinical Imaging Devices: by Type K Units (2020-2025)
  • Figure 65. Global Optical Preclinical Imaging Devices: by Application K Units (2020-2025)
  • Figure 66. Global Optical Preclinical Imaging Devices: by Reagents Types K Units (2020-2025)
  • Figure 67. Global Optical Preclinical Imaging Devices: by Distribution Channel K Units (2020-2025)
  • Figure 68. South America Optical Preclinical Imaging Devices Share (%), by Country
  • Figure 69. Asia Pacific Optical Preclinical Imaging Devices Share (%), by Country
  • Figure 70. Europe Optical Preclinical Imaging Devices Share (%), by Country
  • Figure 71. MEA Optical Preclinical Imaging Devices Share (%), by Country
  • Figure 72. North America Optical Preclinical Imaging Devices Share (%), by Country
  • Figure 73. Global Optical Preclinical Imaging Devices: by Type USD/Units (2020-2025)
Some of the key companies/manufacturers profiled in the report
  • ThermoFisher Scientific (United States)
  • Bruker Corporation (United States)
  • Perkin Elmer (United States)
  • MR Solutions (United Kingdom)
  • BioTek Instruments (United States)
  • Milabs (Netherlands)
  • FUJIFILM Visualsonics, Inc. (Canada)
  • Magnetic Insight Inc. (United States)
  • MBF Bioscience (United States)
  • Mediso (Budapest)
  • LI-COR Biosciences (United States)
  • Aspect Imaging (Israel)
  • TriFoil Imaging (United States)
  • Miltenyi Biotech GmbH (Germany)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation